Attached files
| file | filename |
|---|---|
| EX-99.1 - PRESS RELEASE - Brooklyn ImmunoTherapeutics, Inc. | ntn_8k-ex9901.htm |
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 22, 2012
NTN BUZZTIME, INC.
(Exact name of registrant as specified in its charter)
Delaware
(State or Other Jurisdiction of Incorporation)
| 001-11460 | 31-1103425 | |
| (Commission File Number) |
(IRS Employer Identification No.) | |
|
2231 Rutherford Road, Suite 200 Carlsbad, California |
92008 | |
| (Address of Principal Executive Offices) | (Zip Code) | |
(760) 438-7400
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ¨ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
On February 22, 2012, we issued a press release announcing the preliminary results of our previously announced rights offering, which expired at 5:00 p.m., Eastern time, on February 21, 2012. A copy of the press release is included as an exhibit to this report and is incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
99.1 Press Release dated February 22, 2012
| 2 |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| NTN BUZZTIME, INC. | ||
| Dated: February 22, 2012 | By: | /s/ Kendra Berger |
|
Kendra Berger Chief Financial Officer | ||
| 3 |
EXHIBIT INDEX
| Exhibit No. | Document |
| 99.1 | Press Release dated February 22, 2012 |
4